Abstract:In this study, we aimed to determine an effective strategy for the synthesis of folate receptor (FR) targeted-nanoparticles (FRNPs). The nanoparticles used as ultrasound contrast agents (UCAs) were composed of a liquid core of perfluorooctyl bromide (PFOB) liposome and a targeted shell chemically conjugated with folic acid (FA) and polyethylene glycol (PEG). This was done in order to avoid recognition and clearance by the mononuclear phagocyte system [also known as the reticuloendothelial system (RES)] and enhance the targeting capability of the nanoparticles to tumors over-expressing folate receptor (FR). The FRNPs exhibited an average particle size of 301 +/- 10.8 nm and surface potential of 39.1 +/- 0.43 mV. Subsequently, in vitro, FRNPs labeled with FITC fluorescence dye were visibly uptaken into the cytoplasm of FR-overexpressing cancer cells (Bel7402 and SW620 cells), whereas the A549 cells expressing relatively low levels of FR just bound with few FRNPs. These results demonstrated that FRNPs have a high affinity to FR-overexpressing cancer cells. Additionally, in in vivo experiments, FRNPs achieved a greater enhancement of tumor ultrasound imaging and a longer enhancement time in FR-overexpressing tumors and the Cy7-labeled FRNPs exhibited a relatively high tumor-targeted distribution in FR-overexpressing tumors. Targeted ultrasound and fluorescence imaging revealed that FRNPs have the ability to target FR-overexpressing tumors and ex vivo fluorescence imaging was then used to further verify and confirm the presence of FRNPs in tumor tissues with histological analysis of the tumor slices. On the whole, our data demonstrate that the FRNPs may prove to be a promising candidate for the early diagnosis for FR-overexpressing tumors at the molecular and cellular levels.

Protein-Labeling Fluorescent Probe for Folate Receptor α

Folic Acid-Conjugated Fluorescent Polymer for Up-Regulation Folate Receptor Expression Study Via Targeted Imaging of Tumor Cells.

Folate Receptor Targeting Silica Nanoparticle Probe for Two-Photon Fluorescence Bioimaging.

Terminal Protection-Mediated Autocatalytic Cascade Amplification Coupled with Graphene Oxide Fluorescence Switch for Sensitive and Rapid Detection of Folate Receptor

Terminal protection of small molecule-linked ssDNA for label-free and sensitive fluorescent detection of folate receptor.

Folate-Polyethylene Glycol Conjugated Near-Infrared Fluorescence Probe with High Targeting Affinity and Sensitivity for in Vivo Early Tumor Diagnosis

Folate Receptor Targeting Probes for Two-Photon Fluorescence Bioimaging

Distinguishing folate-receptor-positive cells from folate-receptor-negative cells using a fluorescence off-on nanoprobe.

Synthesis of folate receptor-targeted nanoprobe for detection of cancer cells and its spectral analysis

Fluorescence biosensor for folate receptors in cancer cells based on terminal protection and hyperbranched rolling circle amplification

Folate Receptor Alpha—A Novel Approach to Cancer Therapy

Synthesis of novel folate conjugated fluorescent nanoparticles for tumor imaging.

Folate Receptor-Targeted Ultrasonic PFOB Nanoparticles: Synthesis, Characterization and Application in Tumor-Targeted Imaging

Noninvasive imaging of FAP expression using positron emission tomography: A comparative evaluation of a [18F]-labeled glycopeptide-containing FAPI with [18F]FAPI-42

Terminal protection of small molecule-linked ssDNA for label-free and highly sensitive colorimetric detection of folate receptor biomarkers

The Role of Folate Receptors in the Targeted Diagnosis and Treatment of Carcinoma

Folate Receptor-Targeted Aggregation-Enhanced Near-IR Emitting Silica Nanoprobe for One-Photon in Vivo and Two-Photon Ex Vivo Fluorescence Bioimaging

Folate Receptor Targeting and Cathepsin B-Sensitive Drug Delivery System for Selective Cancer Cell Death and Imaging.

Non-covalent Decoration of Carbon Dots with Folic Acid Via a Polymer-Assisted Strategy for Fast and Targeted Cancer Cell Fluorescence Imaging

18F-labeled FGFR1 peptide: a new PET probe for subtype FGFR1 receptor imaging

Targeted Proteomics Enables Simultaneous Quantification of Folate Receptor Isoforms and Potential Isoform-based Diagnosis in Breast Cancer